GLP-1 Advanced Stack
Triple-agonist and amylin analogue for metabolic research.
- • Retatrutide
- • Cagrilintide
For research use only. Not for human consumption. Products are intended for laboratory and research purposes.
Retatrutide and Cagrilintide paired for research programmes investigating multi-receptor GLP-1/GIP/glucagon and amylin pathway interactions.
Studied outcomes
An advanced metabolic-research combination. Retatrutide is studied for multi-receptor (GIP / GLP-1 / glucagon) metabolic signalling, paired with Cagrilintide, an amylin analogue studied for appetite- and energy-balance pathways. Investigated together in metabolic and glycemic-regulation research models.
Protocol notes
Handle both compounds in accordance with published pre-clinical and clinical research protocols. Reconstitute each peptide separately in an appropriate sterile research solvent.